The blockbuster transactions continue in the cannabis space, with Aphria (TSX:APH; OTC:APHQF)’s acquisition of Nuuvera (TSXV:NUU) being the latest, announced on Monday (January 29) for $826 million.
This buyout comes on the heels of fellow LP Aurora Cannabis (TSX:ACB; OTCQB:ACBFF) completing its acquisition of CanniMed Therapeutics (TSX:CMED) for nearly $1.1 billion last week.
According to a joint statement, Aphria will now take command of Nuuvera’s international options, expanding the depth of its international reach. This move comes in the wake of experts predicting the potential for more mergers and acquisition taking place throughout 2018.
“The transaction provides our shareholders with significant value for their investment in Nuuvera and the opportunity to participate in the significant upside of the combined company,” Lorne Abony, CEO of Nuuvera said.

Terms of the buyout from Aphriawhat are inversion deals

Aphria will buy all of Nuuvera’s issued and outstanding common shares, at a price of $8.50 per share. “Nuuvera shareholders will receive $1.00 in cash plus 0.3546 of an Aphria share for each Nuuvera share held which,” the release said.
According to the companies, the buyout will reduce costs from their already established partnership through offtake agreements. On January 11, Aphria and Nuuvera revealed they were in discussions for one of these deals for 60,000 kilograms of cannabis production.
Nuuvera is a smaller producer with intentions on the global cannabis market, counting opportunities in Germany, Israel, and Italy. Its play for the Italian market expanded this month when the company acquired one of the seven licenses to import medical cannabis into the country.


Canadian cannabis market at an international level

With the expected increase in demand for marijuana, Canadian cannabis producers with established business paths are seeking new means of production to meet the interest of in cannabis products, with the recreational legalization of the drug is slated for summer 2018.
On an international level, The international options are opening up for Canadian LPs as well. As companies continue their development plans, markets that are just starting to take off are looking to Canadian producers for guidance and leadership.
Despite the growing excitement for the Canadian cannabis market, both recreational and medical, some companies have started looking beyond that for their overall growth.
According to Bloomberg, Vic Neufeld said in a call with investors, the hope is to have 20 countries under license in a year’s time.

Investor Takeaway

Following the announcement, Nuuvera’s share price rose over 10 percent. On Monday the company closed with a value of $7.73 per share, representing a 10.43 percent increase. This year Nuuvera’s share price has been struggling; at market close on Friday (January 26), its share price had decreased 54.18 percent.
Tim Seymour, a managing partner with Triogem Asset Management tweeted on Monday this deal could open the doors to Aphria having the largest global “footprint.”


During an analyst panel at the Cannabis Lift Expo in Vancouver, the group of experts discussed how merger and acquisition activity in this market could ramp up in 2018. It will be key for investors to keep track of what companies continue their acquisitions.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less